The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation

Nephrology Dialysis Transplantation

Volumn 23, Issue 11, 2008, Pages 3403-3411

  Dorado, Fernando ^a,b   Velasco, Soraya ^a,b   Esparís Ogando, Azucena ^a   Pericacho, Miguel ^a,b   Pandiella, Atanasio ^a   Silva, Juan ^c   López Novoa, José M ^a,b   Rodríguez Barbero, Alicia ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b MINISTERIO DE SANIDAD Y CONSUMO   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Cell contraction; Cell proliferation; Erk5 MAPK; Extracellular matrix; Mesangial cells

Indexed keywords

ANTIBODY; COLLAGEN TYPE 1; EPIDERMAL GROWTH FACTOR; ERK 5 ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE 7; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY; MESANGIUM; MESANGIUM CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; WILD TYPE;

EID: 54149120307     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn333     Document Type: Article

References (58)

1. Menè P, Simonson MS, Dunn MJ. Physiology of the mesangial cell. Physiol Rev 1989; 69: 1347-1424
2. Veis JH. An overview of mesangial cell biology. Contrib Nephrol 1993; 104: 115-126
3. Hawkins NJ, Wakefield D, Charlesworth JA. The role of mesangial cells in glomerular pathology. Pathology 1990; 22: 24-32
4. Hamaguchi A, Kim S, Yano M et al. Activation of glomerular mitogen-activated protein kinases in angiotensin II-mediated hypertension. J Am Soc Nephrol 1998; 9: 372-380
5. Hamaguchi A, Kim S, Izumi Y et al. Chronic activation of glomerular mitogen-activated protein kinases in Dahl salt-sensitive rats. J Am Soc Nephrol 2000; 11: 39-46
6. Awazu, M, Ishikura K, Hida M et al. Mechanisms of mitogen-activated protein kinase activation in experimental diabetes. J Am Soc Nephrol 1999; 10: 738-745
7. Bokemeyer D, Ostendorf T, Kunter U et al. Differential activation of mitogen-activated protein kinases in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 2000; 11: 232-240
8. Bokemeyer D, Sorokin A, Dunn MJ. Multiple intracellular MAP kinase signaling cascades. Kidney Int 1996; 49: 1187-1198
9. Changland KM. Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37-40
10. Widmann C, Gibson S, Jarpe MB et al. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999; 79: 143-180
11. Marshall CJ. Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-185
12. Schaeffer HJ, Weber MJ. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 1999; 19: 2435-2444
13. Abe J, Kusuhara M, Ulevitch RJ et al. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J Biol Chem1996; 271: 16586-16590
14. Kyriakis JM, Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. Bioassays 1996; 18: 567-577
15. Kyriakis JM. Making the connection: coupling of stress-activated ERK/MAPK (extracellular-signal-regulated kinase/mitogen-activated protein kinase) core signaling modules to extracellular stimuli and biological responses. Biochem Soc Symp 1999; 64: 29-48
16. Tian W, Zhang Z, Cohen DM. MAPK signaling and the kidney. Am J Physiol Renal Physiol 2000; 279: F593-F604
17. Lee JD, Ulevitch RJ, Han J. Primary structure of BMK1: a new mammalian MAP kinase. Biochem Biophys Res Comm 1995; 213: 715-724
18. Zhou G, Bao ZQ, Dixon JE. Components of a new human protein kinase signal transduction pathway. Biol Chem 1995; 270: 12665-12669
19. Kato Y, Kravchenko VV, Tapping RI et al. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J 1997; 16: 7054-7066
20. Kasler HG, Victoria J, Duramad O et al. ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain. Mol Cell Biol 2000; 20: 8382-8389
21. Esparís-Ogando A, Díaz-Rodríguez E, Montero JC et al. Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2. Mol Cell Biol 2002; 22: 270-285
22. Esparís-Ogando A, Díaz-Rodríguez E, Pandiella A. Signalling-competent truncated forms of ErbB2 in breast cancer cells: differential regulation by protein kinase C and phosphatidylinositol 3-kinase. Biochem J 1999; 344: 339-348
23. Rodríguez-Barbero A, Rodríguez-López AM, González-Sarmiento R et al. Gentamicin activates rat mesangial cells. A role for platelet activating factor. Kidney Int 1995; 47: 1346-1353
24. Rodríguez-Barbero A, Obreo J, Álvarez-Muñoz P et al. Endoglin modulation of TGF-β1-induced collagen synthesis is dependent on ERK1/2 MAPK activation. Cell Physiol Biochem 2006; 18: 135-142
25. Marinissen MJ, Chiariello M, Pallante M et al. A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5. Mol Cell Biol 1999; 19: 4289-4301
26. Ausubel FM, Brent R, Kingston RE et al. Current Protocols in Molecular Biology. New York: Wiley, 1987
27. Harris RC. Potential physiologic roles for epidermal growth factor in the kidney. Am J Kidney Dis 1991; 17: 627-630
28. Gilbert RE, Wilkinson-Berka JL, Johnson DWet al. Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats. Kidney Int 1998; 54: 1052-1062
29. Yamamoto T, Noble NA, Cohen AH et al. Expression of transforming growth factor-b isoforms in human glomerular diseases. Kidney Int 1996; 49: 461-469
30. Leehey DJ, Singh AK, Alavi N et al. Role of angiotensin II in diabetic nephropathy. Kidney Int 2000; (Suppl 77): S93-S98
31. Couser WG, Johnson RJ. Mechanisms of progressive renal disease in glomerulonephritis. Am J Kidney Dis 1994; 23: 193-198
32. Stockand JD, Sansom SC. Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease. Am J Kidney Dis 1997; 29: 971-981
33. Kato Y, Tapping RI, Huang S et al. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 1998; 395: 713-716
34. Floege J, Topley N, Resch K. Regulation of mesangial cell proliferation. Am J Kidney Dis 1991; 17: 673-676
35. Raviv Z, Kalie E, Seger R. MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation. J Cell Sci 2004; 117: 1773-1784
36. Touyz RM, Yao G, Viel E et al. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J Hypertens 2004; 22: 1141-1149
37. Liu W, Schoenkerman A, Lowe WL Jr. Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells. Am J Physiol Endocrinol Metab 2000; 279: E782-E790
38. Suzaki Y, Yoshizumi M, Kagami S et al. BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions. Kidney Int 2004; 65: 1749-1760
39. Lopez-Novoa JM. Potential role of platelet activating factor in acute renal failure. Kidney Int 1999; 55: 1672-1682
40. Matsubara H, Moriguchi Y, Mori Y et al. Transactivation of EGF receptor induced by angiotensin II regulates fibronectin and TGF-beta gene expression via transcriptional and post-transcriptional mechanisms. Mol Cell Biochem 2000; 212: 187-201
41. Hua H, Munk S, Whiteside CI. Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction. Am J Physiol Renal Physiol 2003; 284: F303-F312
42. Tharaux PL, Stefanski A, Ledoux S et al. EGF and TGF-beta regulate neutral endopeptidase expression in renal vascular smooth muscle cells. Am J Physiol 1997; 272: C1836-C1843
43. Akagi Y, Isaka Y, Arai M et al. Inhibition of TGF-b expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 1996; 50: 148-155
44. Suzuki S, Ebihara I, Tomino Y et al. Transcriptional activation of matrix genes by transforming growth factor-b in mesangial cells. Exp Nephrol 1993; 1: 229-237
45. Tomooka S, Border WA, Marshall BC et al. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 1992; 42: 1462-1469
46. Kopp JB, Factor VM, Mozes M et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 1996; 74: 991-1003
47. Riser BL, Cortes P, Yee J. Modelling the effects of vascular stress in mesangial cells. Curr Opin Nephrol Hypertens 2000; 9: 43-47
48. Abboud HE. Growth factors in glomerulonephritis. Kidney Int 1993; 43: 252-267
49. Floege J, Johnson RJ, Couser WG. Mesangial cells in the pathogenesis of progressive glomerular disease in animal models. Clin Investig 1992; 70: 857-864
50. Menè P, Pugliese F, Cinotti GA. Serotonin and the glomerular mesangium: mechanisms of intracellular signalling. Hypertension 1991; 17: 151-160
51. Stockand JD, Sansom SC. Glomerular mesangial cells: electrophysiology and regulation of contraction. Physiol Rev 1998; 78: 723-744
52. López-Farré A, Gómez-Garre D, Bernabéu F et al. Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF. Kidney Int 1991; 39: 624-630
53. Harris RC, Hoover RL, Jacobson HR et al. Evidence for glomerular actions of epidermal growth factor in the rat. J Clin Invest 1988; 82: 1028-1039
54. Firestone GL, Giampaolo JR, O'Keeffe BA. Stimulus-dependent regulation of the serumand glucocorticoid inducible protein kinase (Sgk) transcription, subcellular localization and enzymatic activity. Cell Physiol Biochem 2003; 13: 1-12
55. Hayashi M, Tapping RI, Chao TH et al. BMK1 mediates growth factor-induced cell proliferation through direct cellular activation of serum and glucocorticoid-inducible kinase. J Biol Chem 2001; 276: 8631-8634
56. Lang F, Klingel K, Wagner CA et al. Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci USA 2000; 97: 8157-8162
57. Lang F, Cohen P. Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms. Sci STKE 2001; 108: RE17
58. Feng Y, Wang Q, Wang Y et al. SGK1-mediated fibronectin formation in diabetic nephropathy. Cell Physiol Biochem 2005; 16: 237-244